NZAX stories
Chatham Rock Phosphate, which was turned down for a consent for seabed mining, has proposed a deal with associate Aorere Resources which would turn Ch.
Enprise Group triumphs on NZAX debut, aims for global impact with innovative business solutions. CEO Loveys eyes future successes.
GeoOp begins trading on the NZAX at NZD $1.00 per share, aiming to accelerate its global expansion with targets in Australia and the US.
Vmob is on the prowl for fresh capital and wants to raise up to $5m in a private placement, with a share purchase plan to follow.
VMob, the Auckland-based smartphone voucher application firm, has completed a backdoor listing on to the stock exchange's small-cap NZAX.
GeoOp to raise $2.4m to fund expansion in Australia through private placement to foreign investors, senior management and the board.
VMob, the NZAX-listed mobile technology company, is shifting its headquarters to San Francisco, and raising about $5m in a private share placement.
VMob says it has delayed a planned listing on the ASX because of on-going commercial negotiations and so management can focus on current sales.
Chatham Rock aims to secure £1.25M for a fresh stab at offshore mining rights, amidst pay cuts and legislative battles.
Enprise Group has bought MYOB EXO practice Global Bizpro for up to $750,000 including earnouts, in the accounting software reseller first acquisiti.
Graham Shaw and Peter Huljich have joined Pushpay Holdings' board as part of the NZAX-listed mobile payment app developer's plan to graduate to the.
GeoOp, the small business app developer, widened its first-half loss as it spent more on product development and sales to chase global growth.
New Zealand share fell, paced by Meridian Energy, Contact Energy and MightyRiverPower as some investors looked to crystalise recent gains.
Shares of RIS Group have resumed trading after the NZAX-listed shell company lodged its overdue annual report, which has been tagged by its auditor.
TruScreen's innovative cervical screening technology makes a promising debut on NZAX, aiming to revolutionize cancer detection globally.
NXT, NZX's new growth focused market, is unlikely to launch this year, as companies wait for new legislation to come into effect and the quiet Chri.
